サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1762257

神経刺激デバイス市場、規模、シェア、動向、産業分析レポート：用途別、デバイス別、地域別、2025年～2034年の市場予測

Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application, Devices, and Region - Market Forecast, 2025-2034

出版日
ページ情報
英文 116 Pages
納期
即日から翌営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=147.09円
神経刺激デバイス市場、規模、シェア、動向、産業分析レポート：用途別、デバイス別、地域別、2025年～2034年の市場予測
出版日: 2025年05月01日
発行: Polaris Market Research
ページ情報: 英文 116 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

Polaris Market Research社の最新調査によると、世界の神経刺激デバイス市場規模は2034年までに236億3,000万米ドルに達する見込みです。この調査レポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

神経刺激デバイス市場は、神経活動を調節するために神経系に電気インパルスを供給する医療機器で構成され、主に慢性疼痛、てんかん、パーキンソン病、本態性振戦、その他の神経疾患の管理に使用されます。

神経疾患の有病率の上昇、低侵襲治療オプションに対する需要の増加、AI統合やワイヤレス刺激などの技術の進歩により、市場は大きな成長を遂げています。神経刺激デバイスの市場機会は、新興市場におけるこれらの装置の採用拡大とともに、認知障害や肥満管理など従来の適応症以外の用途の拡大にあります。

主な動向としては、再充電可能で小型化されたデバイスの開発、業界プレイヤー間の戦略的提携、神経刺激デバイス市場の拡大を促進する規制当局の承認などが挙げられます。ヘルスケアのインフラが整備され、認知度が高まるにつれて、市場は技術革新と進化する患者のニーズに後押しされ、着実な成長を続けています。

神経刺激デバイス市場レポートハイライト

用途別では、慢性疼痛疾患の有病率の上昇と脊髄刺激装置の採用増加により、疼痛管理分野が最大の市場シェアを占めています。

デバイス別では、パーキンソン病や本態性振戦などの運動障害での使用拡大に支えられ、脳深部刺激装置が最も急成長しています。

北米は、高いヘルスケア支出、強力な規制当局の承認、神経刺激デバイスの普及により市場をリードしています。

アジア太平洋は、ヘルスケアインフラの改善、認知度の向上、神経疾患の有病率の増加を背景に、大きな成長を遂げています。

神経刺激デバイス市場には、医療技術の進歩に積極的に貢献している主要企業が複数あります。主な企業は、Abbott Laboratories、Aleva Neurotherapeutics、Boston Scientific Corporation、Cognito Therapeutics、ElectroCore, Inc、LivaNova PLC、Medtronic plc、Nalu Medical, Inc、Neuronetics, Inc、NeuroPace, Inc、Nevro Corp、Synapse Biomedical Incなどです。

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 調査手法

第4章 世界の神経刺激デバイス市場の洞察

  • 市場スナップショット
  • 神経刺激デバイス市場力学
    • 促進要因と機会
      • 神経疾患の有病率の上昇
      • 神経刺激技術の進歩
    • 抑制要因と課題
      • 機器と処置の高コスト
  • PESTEL分析
  • 神経刺激デバイスの市場動向
  • バリューチェーン分析
  • COVID-19の影響分析

第5章 世界の神経刺激デバイス市場：用途別

  • 主な調査結果
  • イントロダクション
  • 疼痛管理
  • てんかん
  • 本態性振戦
  • 尿失禁と便失禁
  • うつ

第6章 世界の神経刺激デバイス市場：デバイス別

  • 主な調査結果
  • イントロダクション
  • 脊髄刺激デバイス
  • 脳深部刺激デバイス
  • 仙骨神経刺激デバイス
  • 迷走神経刺激デバイス
  • 胃電気刺激デバイス

第7章 世界の神経刺激デバイス市場：地域

  • 主な調査結果
  • イントロダクション
    • 神経刺激デバイス市場分析：地域、2020年～2034年
  • 北米
    • 北米：用途別、2020～2034年
    • 北米：デバイス別、2020～2034年
    • 米国
    • カナダ
  • 欧州
    • 欧州：用途別、2020～2034年
    • 欧州：デバイス別、2020～2034年
    • 英国
    • フランス
    • ドイツ
    • イタリア
    • スペイン
    • オランダ
    • ロシア
    • その他欧州
  • アジア太平洋
    • アジア太平洋地域：用途別、2020～2034年
    • アジア太平洋地域：デバイス別、2020～2034年
    • 中国
    • インド
    • マレーシア
    • 日本
    • インドネシア
    • 韓国
    • オーストラリア
    • その他アジア太平洋地域
  • 中東・アフリカ
    • 中東・アフリカ：用途別、2020～2034年
    • 中東・アフリカ：デバイス別、2020～2034年
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • 南アフリカ
    • その他中東とアフリカ
  • ラテンアメリカ
    • ラテンアメリカ：用途別、2020～2034年
    • ラテンアメリカ：デバイス別、2020～2034年
    • メキシコ
    • ブラジル
    • アルゼンチン
    • その他ラテンアメリカ

第8章 競合情勢

  • 拡大と買収の分析
    • 拡大
    • 買収
  • 提携/協業/合意/公開

第9章 企業プロファイル

  • Abbott Laboratories
  • Advanced Bionics（a Sonova Group company）
  • Aleva Neurotherapeutics
  • Boston Scientific Corporation
  • Cochlear Limited
  • Cognito Therapeutics
  • ElectroCore, Inc.
  • Inspire Medical Systems, Inc.
  • LivaNova PLC
  • Medtronic plc
図表

List of Tables:

  • Table 1 Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 2 Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 3 North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 4 North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 5 U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 6 U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 7 Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 8 Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 9 Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 10 Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 11 UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 12 UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 13 France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 14 France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 15 Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 16 Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 17 Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 18 Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 19 Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 20 Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 21 Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 22 Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 23 Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 24 Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 25 Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 26 Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 27 Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 28 Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 29 China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 30 China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 31 India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 32 India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 33 Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 34 Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 35 Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 36 Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 37 Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 38 Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 39 South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 40 South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 41 Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 42 Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 43 Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 44 Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 45 Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 46 Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 47 Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 48 Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 49 UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 50 UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 51 Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 52 Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 53 South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 54 South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 55 Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 56 Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 57 Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 58 Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 59 Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 60 Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 61 Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 62 Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 63 Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 64 Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • Table 65 Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • Table 66 Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

List of Figures:

  • Figure 1. Global Neurostimulation Devices Market, 2020-2034 (USD Billion)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Price
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Application
  • Figure 7. Global Neurostimulation Devices Market, by Application, 2024 & 2034 (USD Billion)
  • Figure 8. Market by Devices
  • Figure 9. Global Neurostimulation Devices Market, by Devices, 2024 & 2034 (USD Billion)
目次
Product Code: PM3256

The global neurostimulation devices market size is expected to reach USD 23.63 billion by 2034, according to a new study by Polaris Market Research. The report "Neurostimulation Devices Market Size, Share, Trends, Industry Analysis Report: By Application (Pain Management, Epilepsy, Essential Tremor, Urinary & Faecal Incontinence, and Depression), Devices, and Region (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa) - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The neurostimulation devices market consists of medical devices that deliver electrical impulses to the nervous system to modulate neural activity, primarily used for managing chronic pain, epilepsy, Parkinson's disease, essential tremor, and other neurological conditions.

The market is experiencing significant growth due to the rising prevalence of neurological disorders, increasing demand for minimally invasive treatment options, and advancements in technology, including AI integration and wireless stimulation. Neurostimulation devices market opportunities lie in expanding applications beyond traditional indications, such as in cognitive disorders and obesity management, along with the growing adoption of these devices in emerging markets.

Key trends include the development of rechargeable and miniaturized devices, strategic collaborations among industry players, and regulatory approvals facilitating neurostimulation devices market expansion. As healthcare infrastructure improves and awareness increases, the market continues to witness steady growth, driven by innovation and evolving patient needs.

Neurostimulation Devices Market Report Highlights

By application, the pain management segment holds the largest market share due to the rising prevalence of chronic pain conditions and the increasing adoption of spinal cord stimulators.

By devices, the deep brain stimulators segment is experiencing the fastest growth, supported by their expanding use in movement disorders such as Parkinson's disease and essential tremor.

North America leads the market due to high healthcare spending, strong regulatory approvals, and widespread adoption of neurostimulation devices.

Asia Pacific is experiencing significant growth, driven by improving healthcare infrastructure, rising awareness, and increasing prevalence of neurological disorders.

The neurostimulation devices market features several key players actively contributing to advancements in medical technology. Prominent companies include Abbott Laboratories; Aleva Neurotherapeutics; Boston Scientific Corporation; Cognito Therapeutics; ElectroCore, Inc.; LivaNova PLC; Medtronic plc; Nalu Medical, Inc.; Neuronetics, Inc.; NeuroPace, Inc.; Nevro Corp.; and Synapse Biomedical Inc.

Polaris Market Research has segmented the neurostimulation devices market report on the basis of application, devices, and region:

By Application Outlook (Revenue - USD Billion, 2020-2034)

Pain Management

Epilepsy

Essential Tremor

Urinary & Faecal Incontinence

Depression

By Devices Outlook (Revenue - USD Billion, 2020-2034)

Spinal Cord Stimulator

Deep Brain Stimulator

Sacral Nerve Stimulator

Vagus Nerve Stimulator

Gastric Electric Stimulator

By Regional Outlook (Revenue - USD Billion, 2020-2034)

North America

US

Canada

Europe

Germany

France

UK

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

Malaysia

South Korea

Indonesia

Australia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

South Africa

Rest of Middle East & Africa

Latin America

Mexico

Brazil

Argentina

Rest of Latin America

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Neurostimulation Devices Market Insights

  • 4.1. Neurostimulation Devices Market - Market Snapshot
  • 4.2. Neurostimulation Devices Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising Prevalence of Neurological Disorders
      • 4.2.1.2. Advancements in Neurostimulation Technology
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. High Cost of Devices and Procedures
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Neurostimulation Devices Market Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Neurostimulation Devices Market, by Application

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
  • 5.3. Pain Management
    • 5.3.1. Global Neurostimulation Devices Market, by Pain Management, by Region, 2020-2034 (USD Billion)
  • 5.4. Epilepsy
    • 5.4.1. Global Neurostimulation Devices Market, by Epilepsy, by Region, 2020-2034 (USD Billion)
  • 5.5. Essential Tremor
    • 5.5.1. Global Neurostimulation Devices Market, by Essential Tremor, by Region, 2020-2034 (USD Billion)
  • 5.6. Urinary & Faecal Incontinence
    • 5.6.1. Global Neurostimulation Devices Market, by Urinary & Faecal Incontinence, by Region, 2020-2034 (USD Billion)
  • 5.7. Depression
    • 5.7.1. Global Neurostimulation Devices Market, by Depression, by Region, 2020-2034 (USD Billion)

6. Global Neurostimulation Devices Market, by Devices

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 6.3. Spinal Cord Stimulator
    • 6.3.1. Global Neurostimulation Devices Market, by Spinal Cord Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.4. Deep Brain Stimulator
    • 6.4.1. Global Neurostimulation Devices Market, by Deep Brain Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.5. Sacral Nerve Stimulator
    • 6.5.1. Global Neurostimulation Devices Market, by Sacral Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.6. Vagus Nerve Stimulator
    • 6.6.1. Global Neurostimulation Devices Market, by Vagus Nerve Stimulator, by Region, 2020-2034 (USD Billion)
  • 6.7. Gastric Electric Stimulator
    • 6.7.1. Global Neurostimulation Devices Market, by Gastric Electric Stimulator, by Region, 2020-2034 (USD Billion)

7. Global Neurostimulation Devices Market, by Geography

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Neurostimulation Devices Market Assessment, By Geography, 2020-2034 (USD Billion)
  • 7.3. Neurostimulation Devices Market - North America
    • 7.3.1. North America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.3.2. North America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.3. Neurostimulation Devices Market - U.S.
      • 7.3.3.1. U.S.: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.3.2. U.S.: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.3.4. Neurostimulation Devices Market - Canada
      • 7.3.4.1. Canada: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.3.4.2. Canada: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.4. Neurostimulation Devices Market - Europe
    • 7.4.1. Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.4.2. Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.3. Neurostimulation Devices Market - UK
      • 7.4.3.1. UK: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.3.2. UK: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.4. Neurostimulation Devices Market - France
      • 7.4.4.1. France: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.4.2. France: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.5. Neurostimulation Devices Market - Germany
      • 7.4.5.1. Germany: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.5.2. Germany: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.6. Neurostimulation Devices Market - Italy
      • 7.4.6.1. Italy: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.6.2. Italy: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.7. Neurostimulation Devices Market - Spain
      • 7.4.7.1. Spain: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.7.2. Spain: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.8. Neurostimulation Devices Market - Netherlands
      • 7.4.8.1. Netherlands: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.8.2. Netherlands: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.9. Neurostimulation Devices Market - Russia
      • 7.4.9.1. Russia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.9.2. Russia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.4.10. Neurostimulation Devices Market - Rest of Europe
      • 7.4.10.1. Rest of Europe: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.4.10.2. Rest of Europe: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.5. Neurostimulation Devices Market - Asia Pacific
    • 7.5.1. Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.5.2. Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.3. Neurostimulation Devices Market - China
      • 7.5.3.1. China: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.3.2. China: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.4. Neurostimulation Devices Market - India
      • 7.5.4.1. India: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.4.2. India: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.5. Neurostimulation Devices Market - Malaysia
      • 7.5.5.1. Malaysia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.5.2. Malaysia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.6. Neurostimulation Devices Market - Japan
      • 7.5.6.1. Japan: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.6.2. Japan: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.7. Neurostimulation Devices Market - Indonesia
      • 7.5.7.1. Indonesia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.7.2. Indonesia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.8. Neurostimulation Devices Market - South Korea
      • 7.5.8.1. South Korea: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.8.2. South Korea: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.9. Neurostimulation Devices Market - Australia
      • 7.5.9.1. Australia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.9.2. Australia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.5.10. Neurostimulation Devices Market - Rest of Asia Pacific
      • 7.5.10.1. Rest of Asia Pacific: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.5.10.2. Rest of Asia Pacific: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.6. Neurostimulation Devices Market - Middle East & Africa
    • 7.6.1. Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.6.2. Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.3. Neurostimulation Devices Market - Saudi Arabia
      • 7.6.3.1. Saudi Arabia: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.3.2. Saudi Arabia: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.4. Neurostimulation Devices Market - UAE
      • 7.6.4.1. UAE: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.4.2. UAE: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.5. Neurostimulation Devices Market - Israel
      • 7.6.5.1. Israel: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.5.2. Israel: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.6. Neurostimulation Devices Market - South Africa
      • 7.6.6.1. South Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.6.2. South Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.6.7. Neurostimulation Devices Market - Rest of Middle East & Africa
      • 7.6.7.1. Rest of Middle East & Africa: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.6.7.2. Rest of Middle East & Africa: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
  • 7.7. Neurostimulation Devices Market - Latin America
    • 7.7.1. Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
    • 7.7.2. Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.3. Neurostimulation Devices Market - Mexico
      • 7.7.3.1. Mexico: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.3.2. Mexico: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.4. Neurostimulation Devices Market - Brazil
      • 7.7.4.1. Brazil: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.4.2. Brazil: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.5. Neurostimulation Devices Market - Argentina
      • 7.7.5.1. Argentina: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.5.2. Argentina: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)
    • 7.7.6. Neurostimulation Devices Market - Rest of Latin America
      • 7.7.6.1. Rest of Latin America: Neurostimulation Devices Market, by Application, 2020-2034 (USD Billion)
      • 7.7.6.2. Rest of Latin America: Neurostimulation Devices Market, by Devices, 2020-2034 (USD Billion)

8. Competitive Landscape

  • 8.1. Expansion and Acquisition Analysis
    • 8.1.1. Expansion
    • 8.1.2. Acquisitions
  • 8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

  • 9.1. Abbott Laboratories
    • 9.1.1. Company Overview
    • 9.1.2. Financial Performance
    • 9.1.3. Product Benchmarking
    • 9.1.4. Recent Development
  • 9.2. Advanced Bionics (a Sonova Group company)
    • 9.2.1. Company Overview
    • 9.2.2. Financial Performance
    • 9.2.3. Product Benchmarking
    • 9.2.4. Recent Development
  • 9.3. Aleva Neurotherapeutics
    • 9.3.1. Company Overview
    • 9.3.2. Financial Performance
    • 9.3.3. Product Benchmarking
    • 9.3.4. Recent Development
  • 9.4. Boston Scientific Corporation
    • 9.4.1. Company Overview
    • 9.4.2. Financial Performance
    • 9.4.3. Product Benchmarking
    • 9.4.4. Recent Development
  • 9.5. Cochlear Limited
    • 9.5.1. Company Overview
    • 9.5.2. Financial Performance
    • 9.5.3. Product Benchmarking
    • 9.5.4. Recent Development
  • 9.6. Cognito Therapeutics
    • 9.6.1. Company Overview
    • 9.6.2. Financial Performance
    • 9.6.3. Product Benchmarking
    • 9.6.4. Recent Development
  • 9.7. ElectroCore, Inc.
    • 9.7.1. Company Overview
    • 9.7.2. Financial Performance
    • 9.7.3. Product Benchmarking
    • 9.7.4. Recent Development
  • 9.8. Inspire Medical Systems, Inc.
    • 9.8.1. Company Overview
    • 9.8.2. Financial Performance
    • 9.8.3. Product Benchmarking
    • 9.8.4. Recent Development
  • 9.9. LivaNova PLC
    • 9.9.1. Company Overview
    • 9.9.2. Financial Performance
    • 9.9.3. Product Benchmarking
    • 9.9.4. Recent Development
  • 9.10. Medtronic plc
    • 9.10.1. Company Overview
    • 9.10.2. Financial Performance
    • 9.10.3. Product Benchmarking
    • 9.10.4. Recent Development